Iterum Therapeutics PLC

Biotechnology • Healthcare • Dublin, Ireland • ITRM (NCM)

Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

353 1 903 8354 3 Dublin Landings, Ireland

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Analysts Expect Breakeven For Iterum Therapeutics plc (NASDAQ:ITRM) Before Long - Yahoo Finance

Yahoo Finance • Oct 17

Iterum Therapeutics (Nasdaq: ITRM) extends cash runway into Q2 2026; Q3 revenue $0.4M - Stock Titan

Stock Titan • Nov 14

Iterum Therapeutics Faces Nasdaq Listing Compliance Challenge - The Globe and Mail

The Globe and Mail • Dec 13

ITERUM THERAPEUTICS Earnings Preview: Recent $ITRM Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Quiver Quantitative • Nov 12

Iterum therapeutics (ITRM) director Dunne buys $10,854 in shares - Investing.com

Investing.com • Aug 12

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Iterum Therapeutics plc had layoffs?

No layoff events have been recorded for Iterum Therapeutics plc in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Iterum Therapeutics plc have?

Iterum Therapeutics plc has approximately 9 employees.

What industry is Iterum Therapeutics plc in?

Iterum Therapeutics plc operates in the Biotechnology industry, within the Healthcare sector.

Is Iterum Therapeutics plc a publicly traded company?

Yes, Iterum Therapeutics plc is publicly traded under the ticker symbol ITRM on the NCM. The company has a market capitalization of approximately $0.01 billion.

Where is Iterum Therapeutics plc headquartered?

Iterum Therapeutics plc is headquartered in Dublin, Ireland at 3 Dublin Landings, Ireland.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.